Device Warning Letter Pilot Discontinued; OCC Review Cited As Alternative
This article was originally published in The Gray Sheet
Executive Summary
The Medical Device Initiative Grassroots Task Force will be briefed regularly on FDA's warning and untitled letter activities, following the agency's decision to end its device center warning letter pilot program